Investment
Features
FeesSafety
Academy
More
Pluang+

Bitget faces $388M crypto theft; calls for clearer self-custody wallet transaction controls.

Market News
06 Oct 2026
Tokenpost
View Source
Bearish
Bitget faces $388M crypto theft; calls for clearer self-custody wallet transaction controls.

Bitget exchange reported unauthorized transfers totaling about $388 million from some of its hot and warm wallets due to a security breach involving a third-party product vulnerability. The incident, detected on Sept. 24, did not affect Bitget Wallet’s self-custodied assets, which are kept separate from the exchange’s infrastructure. Bitget Wallet COO Alvin Kan advocates for clearer transaction approvals and recovery tools for self-custody wallets to help users better understand and control their crypto transactions. Regulatory bodies like ESMA and the SEC are reviewing crypto custody rules, but current proposals mainly target intermediaries, not individual self-custody users.

The Bitget Wallet Chief's call for clearer controls for self-custody users comes as a backdrop to a mixed market performance among major cryptocurrencies on Pluang. For readers following crypto assets, here is Pluang's market snapshot as of Oct 07, 2026 01:12 WIB: out of 50 major cryptocurrencies, 24 rose and 25 fell. Notable movers include COTI with a price of Rp244 and a 1-day change of -3.31%, Uniswap (UNI) at Rp154,755 down 3.26%, and The Sandbox (SAND) at Rp1,170 down 3.16%.

More News

Bank OZK to report Q3 2026 earnings on Oct 20 amid Citigroup's Sell rating at $45.59

Bank OZK to report Q3 2026 earnings on Oct 20 amid Citigroup's Sell rating at $45.59

Bank OZK is scheduled to release its Q3 2026 earnings after market close on October 20, providing investors with updated financial results to compare against Citigroup's current Sell rating. The bank's latest balance sheet shows $41.70 billion in tot...

Company Fundamentals
Neutral
1 hour ago
Scotiabank raises Pfizer price target to $33, signaling 20.9% potential gain.

Scotiabank raises Pfizer price target to $33, signaling 20.9% potential gain.

Scotiabank has increased its price target for Pfizer stock from $30.00 to $33.00, suggesting a potential upside of 20.9% from the current trading price of $27.31. Pfizer, a major pharmaceutical company, holds a strong buy rating with a Zacks Rank of ...

Analyst Insights
Bullish
1 hour ago
Citigroup raises AstraZeneca price target after strong clinical trial results

Citigroup raises AstraZeneca price target after strong clinical trial results

Citigroup has raised its price target for AstraZeneca to £186.00 from £178.00, maintaining a Buy rating following successful Phase 3 clinical trials. The increase reflects higher peak sales forecasts for drugs tozorakimab and SERENA-6, offsetting the...

Analyst Insights
Bullish
2 hours ago
Devon Energy shares seen rising 40% as analyst sets $67 price target amid asset sale pressures.

Devon Energy shares seen rising 40% as analyst sets $67 price target amid asset sale pressures.

An analyst from BMO Capital set a $67 price target for Devon Energy, suggesting a 40% upside from its current share price of around $48. The oil and gas producer has consistently beaten earnings estimates recently, showing strong financial health. Ho...

Analyst Insights
Bullish
3 hours ago
$10,000 in Marvell stock 10 years ago is now worth about $206,000, needing 35% annual growth to repeat.

$10,000 in Marvell stock 10 years ago is now worth about $206,000, needing 35% annual growth to repeat.

An investment of $10,000 in Marvell stock a decade ago has grown to approximately $206,000 today. Achieving the same growth again would require an annual earnings increase of 35%. This highlights Marvell's strong past performance and the challenge of...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App